Korean red ginseng attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells

Food Science and Biotechnology

Volumn 19, Issue 1, 2010, Pages 207-212

  Quan, Hai Yan ^a   Yuan, Hai Dan ^a   Kim, Do Yeon ^a   Zhang, Ya ^a   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

AMP activated protein kinase; HepG2 hepatoma cell; Korean red ginseng; Peroxisome proliferator activated receptor a; Sterol regulatory element binding protein 1c

Indexed keywords

AMP-ACTIVATED PROTEIN KINASE; HEPATOMA CELLS; KOREAN RED GINSENG; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR A; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ALCOHOLS; CYTOLOGY; ENZYME ACTIVITY; FATTY ACIDS; PHOSPHORYLATION; PROTEINS; TUMORS;

GENE EXPRESSION;

PANAX GINSENG;

EID: 79957635291     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-010-0028-8     Document Type: Article

References (24)

1. Marchesini G, Brizi M, Tomassetti S, Buqianesi E, Lenzi M, McCullough A, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 50: 1884-1850 (2001)
2. Charlton M, Kasparova P, Weston S, Lindor K, Maor-Kendler Y, Wiesner RH, Rosen CB, Batts KP. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transplant. 7: 608-614 (2001)
3. Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: Possible role in type 2 diabetes. Am. J. Physiol. 277: E1-E10 (1999)
4. Viollet B, Guigas B, Leclerc J, Hebrard S, Lantier L, Mounier R, Andreelli F, Foretz M. AMP-activated protein kinase in the regulation of hepatic energy metabolism: From physiology to therapeutic perspectives. Acta Physiol. 196: 81-98 (2009)
5. Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F. Activation of AMP-activated protein kinase in the liver: A new stategy for the management of metabolic hepatic disorders. J. Physiol. 574: 41-53 (2006)
6. Brusq JM, Ancellin N, Grondin P, Guillard R, Martin S, Saintillan Y, Issandou M. Inhibition of lipid synthesis through activation of AMP kinase; an additional mechanism for the hypolipidemic effects of berberine. J. Lipid Res. 47: 1281-1288 (2006)
7. Yu JY, Jin YR, Lee JJ, Chung JH, Noh JY, You SH, Kim KN, Im JH, Lee JH, Seo JM, Han HJ, Lim Y, Park ES, Kim TJ, Shin KS, Wee JJ, Park JD, Yun YP. Antiplatelet and antithrombotic activities of Korean red ginseng. Arch. Pham. Res. 10: 898-903 (2006)
8. Park SE, Park C, Kim SH, Hossain MA, Kim MY, Chung HY, Son WS, Kim GY, Choi YH, Kim ND. Korean red ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells. J. Ethnopharmacol. 121: 304-312 (2009)
9. Yuan HD, Shin EJ, Chung SH. Anti-diabetic effect and mechanism of Korean red ginseng in C57BJ/KsJ db/db mice. J. Ginseng Res. 3: 187-193 (2008)
10. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM. Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity. Cell 113: 159-170 (2003)
11. Wang CZ, Aung HH, Ni M, Wu JA, Tong R, Wicks S, He TC, Yuan CS. Red American ginseng: Ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med. 73: 669-674 (2007)
12. Kim K, Kim HY. Korean red ginseng stimulates insulin release from isolated rat pancreatic islets. J. Ethnopharmacol. 120: 190-195 (2008)
13. Lee HJ, Lee YH, Park SK, Kang ES, Kim HJ, Lee YC, Choi CS, Park SE, Ahn Cw, Cha BS, Lee KW, Kim KS, Lim SK, Lee HC. Korean red ginseng (Panax ginseng) improves insulin sensitivity and attenuates the development of diabetes in Otsuka Long-Evans Tokushima fatty rats. Metabolism 58: 1170-1177 (2009)
14. Hutchinson DS, Summers RJ, Benqtsson T. Regulation of AMPactivated protein kinase by G-protein coupled receptors: Potential utility in treatment of diabetes and heart disease. Pharmacol. Ther. 119: 291-310 (2008)
15. Han R, Lai R, Ding Q, Wang Z, Luo X, Zhang Y, Cui G, He J, Liu W, Chen Y. Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism. Diabetologia 50: 1960-1968 (2007)
16. Kim DY, Yuan HD, Chung IK, Chung SH. Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via AMPK activation in human hepatoma cells. J. Agr. Food Chem. 57: 1532-1537 (2009)
17. Rutter GA, Leclerc I. The AMP-regulated kinase family: Enigmatic targets for diabetes therapy. Mol. Cell Endocrinol. 297: 41-49 (2009)
18. Hardie DG, Pan DA. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem. Soc. Trans. 30: 1064-1070 (2002)
19. Ryu GR, Lee MK, Lee E, Ko SH, Ahn YB, Kim JW, Yoon KH, Song KH. Activation of AMP-activated protein kinase mediates acute and severe hypoxic injury to pancreatic beta cells. Biochem. Bioph. Res. Co. 386: 356-362 (2009)
20. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108: 1167-1174 (2001)
21. Foretz M, Carling D, Guichard G, Ferre P, Foufelle F. AMPactivated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes. J. Biol. Chem. 273: 14767-14771 (1998)
22. Horton JD, Goldstein JL, Brown MS. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109: 1125-1131 (2002)
23. Crabb DW, Lianqpunsakul S. Alcohol and lipid metabolism. J. Gastroen. Hepatol. 21: S56-S60 (2006)
24. Wong J, Quinn CM, Brown AJ. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Biochem. J. 400: 485-491 (2006)